Recombinant LCAT may improve outcomes in these patients and may also provide a potential future drug in the armamentarium against sepsis (Shamburek et al., 2016a; Shamburek et al., 2016b; Ossoli et al., 2019). The gene discussed is LCAT; the disease is Sepsis.